Lead Product(s): RNA Therapeutics
Therapeutic Area: Genetic Disease Product Name: Undisclosed
Highest Development Status: Discovery Platform Product Type: Large molecule
Partner/Sponsor/Collaborator: SoftBank Vision Fund
Deal Size: $180.0 million Upfront Cash: Undisclosed
Deal Type: Series C Financing July 28, 2021
Deep Genomics uses AI and machine learning to program and prioritize transformational RNA therapeutics for genetic diseases. Company expands AI discovery platform for ‘Programmable’ RNA therapeutics and supports advancement of its portfolio into the clinic.